Ongoing clinical trials and approved products targeting Tau, in radioligand therapy and PET/SPECT imaging. Data as of 26 October 2026.
| Tauvid[18F]flortaucipir | Lilly | marketed | US EU FR |
| Tauklarify[18F]florquinitau (MK-6240) | Lantheus | approved (2026) | US |
| Trial | Phase | Status | Sponsor | Countries |
|---|---|---|---|---|
| Tau protein tracersNCT07115238 · Alzheimer's disease and cognitive disorders | Phase 3 | Recruiting | Sinotau Pharmaceutical Group | 1 |
| Tau protein tracersNCT05641688 · Alzheimer's disease and cognitive disorders | Phase 3 | Recruiting | Lantheus Biosciences Ltd. | 1 |
| Tau protein tracersNCT07422857 · Alzheimer's disease and cognitive disorders | Phase 3 | Recruiting | JYAMS PET Research & Development Limited | 1 |
| Tau protein tracers2024-517074-17-00 · Alzheimer's disease and cognitive disorders | Phase 3 | Recruiting | Cliniques Universitaires Saint-Luc | 1 |
| Tau protein tracersNCT03143374 · Other neurodegenerative diseases | Phase 3 | Recruiting | University of Pennsylvania | 1 |
| Tau protein tracers2023-505430-10-00 · Alzheimer's disease and cognitive disorders | Phase 3 | Recruiting | Amsterdam UMC | 1 |
| Tau protein tracersNCT05456503 · Alzheimer's disease and cognitive disorders | Phase 3 | Recruiting | University of Pennsylvania | 1 |
| Tau protein tracersNCT07752784 · Alzheimer's disease and cognitive disorders | Phase 3 | Recruiting | JYAMS PET Research & Development Limited | 1 |
| Tau protein tracers2024-519995-20-00 · Alzheimer's disease and cognitive disorders | Phase 3 | Not yet recruiting | Institut National De La Sante Et De La Recherche Medicale | 1 |
| Quanti-TAU-PET · Tau protein tracersNCT07105384 · Parkinson's disease and parkinsonian syndromes | Phase 2 | Active, not recruiting | Fundacion Clinic per a la Recerca Biomédica | 1 |
| NOMEM-Tau · Tau protein tracersNCT03389100 · Diabetes and obesity | Phase 2 | By invitation | Columbia University | 1 |
| Tau protein tracersNCT06723015 · Alzheimer's disease and cognitive disorders | Phase 2 | By invitation | Mayo Clinic | 1 |
| Tau protein tracersNCT07020026 · Parkinson's disease and parkinsonian syndromes | Phase 2 | Recruiting | Michael J. Fox Foundation for Parkinson's Research | 1 |
| Tau protein tracers2024-515574-27-00 · Alzheimer's disease and cognitive disorders | Phase 2 | Recruiting | Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau | 1 |
| Tau protein tracers2024-517048-67-00 · Stroke and trauma | Phase 2 | Recruiting | Region Skane | 1 |
| Tau protein tracers2024-517634-17-01 · Alzheimer's disease and cognitive disorders | Phase 2 | Recruiting | Amsterdam UMC Stichting | 1 |
| Tau protein tracers2025-522826-11-00 · Alzheimer's disease and cognitive disorders | Phase 2 | Recruiting | ZRO Imaging AB | 1 |
| Tau protein tracers2023-503538-37-00 · Parkinson's disease and parkinsonian syndromes | Phase 2 | Recruiting | University Clinic Of Navarra | 1 |
| Tau protein tracersNCT06297590 · Alzheimer's disease and cognitive disorders | Phase 1 | Recruiting | Eli Lilly and Company | 3 |
| Tau protein tracersNCT05464368 · Alzheimer's disease and cognitive disorders | Phase 1 | Active, not recruiting | Washington University School of Medicine | 1 |
| AV1451 ADC · Tau protein tracersNCT03809351 · Alzheimer's disease and cognitive disorders | Phase 1 | Recruiting | University of Alabama at Birmingham | 1 |
| Tau protein tracersNCT07580703 · Alzheimer's disease and cognitive disorders | Phase 1 | Recruiting | Eli Radiopharma | 1 |
| Tau protein tracersNCT02605785 · Parkinson's disease and parkinsonian syndromes | No phase | Recruiting | Mayo Clinic | 1 |
| Add-Tau · Tau protein tracersNCT02958670 · Alzheimer's disease and cognitive disorders | No phase | Active, not recruiting | University of Zurich | 1 |
| Tau protein tracersNCT04482660 · Alzheimer's disease and cognitive disorders | No phase | By invitation | Barcelonabeta Brain Research Center, Pasqual Maragall Foundation | 1 |
| ROADAD · Tau protein tracersNCT06731842 · Alzheimer's disease and cognitive disorders | No phase | By invitation | Karolinska Institutet | 1 |
Tau. Theranostic Atlas, LaRadiopharmacie.fr. Data as of 26 October 2026. https://theranosticatlas.com/target/tau/ (accessed [date]).
A monitoring tool with no regulatory value: check every item at its source.